2 Article(s)Download |
PMID | Title | Pub. Year | #Total Relationships |
| 1 | 33160017 | The SGLT2 inhibitor Empagliflozin attenuates interleukin-17A-induced human aortic smooth muscle cell proliferation and migration by targeting TRAF3IP2/ROS/NLRP3/Caspase-1-dependent IL-1β and IL-18 secretion. | 2021 Jan | 2 |
| 2 | 32358544 | SGLT2 inhibition modulates NLRP3 inflammasome activity via ketones and insulin in diabetes with cardiovascular disease. | 2020 May 1 | 1 |